Literature DB >> 7631352

Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model.

T B Müller1, O Haraldseth, R A Jones, G Sebastiani, C F Lindboe, G Unsgård, A N Oksendal.   

Abstract

BACKGROUND AND
PURPOSE: The present study was performed to examine the potential of diffusion-weighted (DW) imaging and dynamic first-passage bolus tracking of susceptibility contrast agents (perfusion imaging) for early in vivo evaluation of the effects of treatment with the free radical scavenger U74389G in a rat model of temporary focal ischemia.
METHODS: After 45 minutes of middle cerebral artery occlusion, the treatment group (n = 9) received an infusion of U74389G, and the control group (n = 9) received the identical volume of the vehicle. Reperfusion was instituted in both groups after 120 minutes of middle cerebral artery occlusion. The DW images were collected during middle cerebral artery occlusion and reperfusion and were compared with histologically assessed areas of tissue injury after 2 hours of reperfusion. The dynamic perfusion series were processed on a pixel-to-pixel basis to produce parametric maps reflecting the maximum reduction in the signal obtained during the first passage of the contrast agent and the time delay between the arrival of the bolus and the point of maximum contrast-agent effect.
RESULTS: The area of ischemic injury, as assessed from the DW imaging at 60 minutes of reperfusion, was significantly smaller in the treatment group: 9 +/- 8% of ipsilateral hemisphere compared with 19 +/- 8% in the control group. The histological examination after 2 hours of reperfusion demonstrated an area of ischemic injury of 10 +/- 8% for the treatment group compared to 25 +/- 10% in the control group. In the treatment group, the perfusion imaging showed a reduction in time delay to maximum effect of the contrast agent in the ischemic hemisphere compared with the control group.
CONCLUSIONS: The DW imaging during early reperfusion showed a protective effect of postocclusion treatment with the free radical scavenger U74389G. The improvement of time delay to maximum effect of the contrast agent observed in the perfusion imaging of the treatment group may reflect an improvement in the collateral flow to the ischemic tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631352     DOI: 10.1161/01.str.26.8.1453

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Cerebral perfusion alterations during the acute phase of experimental generalized status epilepticus: prediction of survival by using perfusion-weighted MR imaging and histopathology.

Authors:  T Engelhorn; A Doerfler; J Weise; M Baehr; M Forsting; A Hufnagel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 2.  Epileptogenesis after experimental focal cerebral ischemia.

Authors:  Heli Karhunen; Jukka Jolkkonen; Juhani Sivenius; Asla Pitkänen
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Does a relative perfusion measure predict cerebral infarct size?

Authors:  Tobias Engelhorn; Arnd Doerfler; Michael Forsting; Gerd Heusch; Rainer Schulz
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

4.  Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro.

Authors:  R Durmaz; S Deliorman; S Isiksoy; R Uyar; K Erol; E Tel
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

6.  Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex.

Authors:  David Nagy; Mate Marosi; Zsolt Kis; Tamas Farkas; Gabriella Rakos; Laszlo Vecsei; Vivian I Teichberg; Jozsef Toldi
Journal:  Cell Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.046

7.  Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model.

Authors:  Preeti Dohare; Puja Garg; Uma Sharma; N R Jagannathan; Madhur Ray
Journal:  BMC Complement Altern Med       Date:  2008-09-30       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.